Neuroone Medical Technologies is trading 6.05% down at $2.02, with the decline appearing to reflect ongoing volatility and profit-taking following recent sharp gains.
- Broader markets were modestly higher, while the healthcare sector gained 1.29%.
- No company-specific announcement or fresh catalyst was identified for August 21, 2026.
- Latest identifiable event was the August 13 fiscal Q3 report, which showed 16% revenue growth and 59.9% gross margins, but also a wider net loss and manufacturing constraints; trading volume and activity-level data were unavailable.